About the group.
Firalis Group grew out of Firalis, a biomarker company based in Huningue, on the Rhine at the crossroads of France, Germany and Switzerland. Since then, the Group has grown through the creation and acquisition of companies, each bringing its own area of expertise.
Firalis is founded. It begins coordinating European collaborative research with university hospitals, clinical centres and biobanks.
The research network is reinforced through strategic technology investments and acquisitions, bringing complementary expertise and intellectual property.
The Group acquired the assets of a biotech company holding patents in neurodegenerative disorders and founded Amoneta.
Lodiag is created to detect and measure micropollutants in water and other complex samples.
Firalis sells its majority stake in Firalis Molecular Precision to Janvier Group Biosciences. The business now operates as Precursion, and Firalis remains a minority shareholder.
Firalis acquires BioCellvia.
Today
Firalis Group brings together complementary companies and expertise across biomarker discovery, diagnostics, biopharma and environmental technologies, connected by a common commitment to translating science into impact.
Location
On the border of three countries.
Huningue is a French town on the Rhine, with Switzerland and Germany on its doorstep. The map and the ways in by air, rail and road are on the contact page.
France
Huningue
Germany
Weil am Rhein
Across the river, by the Passerelle des Trois Pays: a 248-metre bridge for pedestrians and cyclists, open since 2007.
Switzerland
Basel
Over the border to the south: Huningue is a northern suburb of the city.
BioCellvia is based in Marseille, France.
Discover the Firalis Group.
Explore the companies, expertise and people behind the Firalis Group. From our roots in Huningue to our complementary activities, discover the different facets of our Group.